Your browser doesn't support javascript.
loading
SILEN-C3, a phase 2 randomized trial with faldaprevir plus pegylated interferon α-2a and ribavirin in treatment-naive hepatitis C virus genotype 1-infected patients.
Dieterich, Douglas; Asselah, Tarik; Guyader, Dominique; Berg, Thomas; Schuchmann, Marcus; Mauss, Stefan; Ratziu, Vlad; Ferenci, Peter; Larrey, Dominique; Maieron, Andreas; Stern, Jerry O; Ozan, Melek; Datsenko, Yakov; Böcher, Wulf Otto; Steinmann, Gerhard.
Afiliação
  • Dieterich D; Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA douglas.dieterich@mountsinai.org.
  • Asselah T; Service d'Hépatologie, AP-HP Hôpital Beaujon, INSERM UMR 1149, CRI, Université Paris Diderot, Clichy, France.
  • Guyader D; Department of Liver Diseases, University of Rennes 1, Rennes, France.
  • Berg T; Sektion Hepatologie, Department für Innere Medizin, Neurologie und Dermatologie, Klinik für Gastroenterologie und Rheumatologie, Universitätsklinik Leipzig AöR, Leipzig, Germany.
  • Schuchmann M; Klinik für Innere Medizin, Klinikum Konzstanz, Constance, Germany.
  • Mauss S; Center for HIV and Hepatogastroenterology, Düsseldorf, Germany.
  • Ratziu V; Service d'Hépato-Gastroentérologie, Hôpital Pitié-Salpêtrière, Paris, France.
  • Ferenci P; Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
  • Larrey D; Liver Unit-IRB-INSERM1040, Hôpital Saint Eloi, Montpellier, France.
  • Maieron A; Department of Gastroenterology and Hepatology, Elisabethinen Hospital Linz, Linz, Austria.
  • Stern JO; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.
  • Ozan M; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.
  • Datsenko Y; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
  • Böcher WO; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
  • Steinmann G; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
Antimicrob Agents Chemother ; 58(6): 3429-36, 2014 Jun.
Article em En | MEDLINE | ID: mdl-24709256
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Oligopeptídeos / Polietilenoglicóis / Ribavirina / Tiazóis / Interferon-alfa / Hepatite C / Hepacivirus Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Oligopeptídeos / Polietilenoglicóis / Ribavirina / Tiazóis / Interferon-alfa / Hepatite C / Hepacivirus Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos